Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
Authors
Keywords
Proteinuria, Histology, Kidneys, Lesions, Enzyme-linked immunoassays, Statistical data, Steroid therapy, Biomarkers
Journal
PLoS One
Volume 13, Issue 11, Pages e0206865
Publisher
Public Library of Science (PLoS)
Online
2018-11-03
DOI
10.1371/journal.pone.0206865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis
- (2018) Hitoshi Suzuki et al. KIDNEY INTERNATIONAL
- Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
- (2018) William J. Placzek et al. PLoS One
- GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway
- (2017) Krzysztof Kiryluk et al. PLoS Genetics
- Biomarkers of IgA vasculitis nephritis in children
- (2017) Evangeline Pillebout et al. PLoS One
- Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
- (2016) Hitoshi Suzuki et al. DISEASE MARKERS
- Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients
- (2016) Rosanna Coppo JOURNAL OF NEPHROLOGY
- Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
- (2016) Rosanna Coppo et al. PEDIATRIC NEPHROLOGY
- Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
- (2016) Kei Hihara et al. PLoS One
- Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
- (2016) Min Jeong Kim et al. PLoS One
- Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
- (2016) Qiang Sun et al. PLoS One
- Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes
- (2015) Laureline Berthelot et al. KIDNEY INTERNATIONAL
- Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
- (2015) Junichi Yasutake et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
- (2014) Yusuke Suzuki et al. Clinical and Experimental Nephrology
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cytokines Alter IgA1O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
- (2014) Hitoshi Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The genetics and immunobiology of IgA nephropathy
- (2014) Krzysztof Kiryluk et al. JOURNAL OF CLINICAL INVESTIGATION
- A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
- (2014) T. Kawamura et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
- (2014) Junichiro Nakata et al. PLoS One
- A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
- (2014) Hiroyuki Yanagawa et al. PLoS One
- Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats
- (2014) Yukihiro Wada et al. PLoS One
- Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
- (2012) Yukihiro Wada et al. Clinical and Experimental Nephrology
- A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease
- (2012) Tetsuya Kawamura et al. JOURNAL OF NEPHROLOGY
- Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria
- (2012) E. Gutierrez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
- (2012) F. Berthoux et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
- (2012) Na Zhao et al. KIDNEY INTERNATIONAL
- A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission?
- (2011) Hirokazu Imai et al. Clinical and Experimental Nephrology
- Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
- (2011) R. Camilla et al. Clinical Journal of the American Society of Nephrology
- Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
- (2011) M. Iyoda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
- (2010) M. C. Hastings et al. Clinical Journal of the American Society of Nephrology
- The incidence of primary glomerulonephritis worldwide: a systematic review of the literature
- (2010) A. McGrogan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
- (2009) Ian S.D. Roberts et al. KIDNEY INTERNATIONAL
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
- (2009) Daniel C. Cattran et al. KIDNEY INTERNATIONAL
- Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy
- (2008) S. Shimozato et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started